Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
764.440.02%
QQQ
715.040.02%
BTC/USD
77639.971.0939%
DIA
525.910.02%
GLD
398.290.12%
TLT
80.930.07%

Fractyl Health Inc

GUTSNASDAQ
Trade with Public
Trade with Public
$0.6400
-0.0031-0.48%
At close: Sep 11, 5:00 PM EST
$0.6400
N/A
After Hours: Sep 11, 6:16 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

Fractyl Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Fractyl Health (GUTS).

Price Target Range — 8 Quarters

Analyst Consensus — 5 Analysts

5Buy
Consensus RatingBuy# Analysts5Avg. Consensus PT$6Upside to Avg. PT+879.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Jul 1, 2026Craig-HallumChase KnickerbockerInitiateBuy$4
Jun 4, 2026HC Wainwright & Co.Joseph PantginisMaintainedBuy$8
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Fractyl Health (NASDAQ:GUTS) with a Buy and maintains $8 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Fractyl Health (NASDAQ:GUTS) with a Buy and maintains $8 price target.
Benzinga Newsdesk

PRO
Morgan Stanley Downgrades Fractyl Health to Equal-Weight, Lowers Price Target to $2

Morgan Stanley analyst Michael Ulz downgrades Fractyl Health (NASDAQ:GUTS) from Overweight to Equal-Weight and lowers the price target from $8 to $2.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Fractyl Health (NASDAQ:GUTS) with a Buy and maintains $8 price target.
Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on Fractyl Health, Raises Price Target to $8

Canaccord Genuity analyst Whitney Ijem maintains Fractyl Health (NASDAQ:GUTS) with a Buy and raises the price target from $6 to $8.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Fractyl Health, Lowers Price Target to $8

HC Wainwright & Co. analyst Joseph Pantginis maintains Fractyl Health (NASDAQ: GUTS) with a Buy and lowers the price target from $9 to $8.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved